US Pharma MarketingThe startup claims to have a “differentiated” antibody that can provide long-lasting protection against a variety of influenza strains.
Investors pour $115M into RQ Bio in search of a preventive flu drug
Investors pour $115M into RQ Bio in search of a preventive flu drug is a pharma and life sciences industry update from BioPharma Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: BioPharma Dive